Literature DB >> 4688655

Immunologic models used for the study of rheumatoid arthritis.

H E Jasin, T D Cooke, E R Hurd, J D Smiley, M Ziff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4688655

Source DB:  PubMed          Journal:  Fed Proc        ISSN： 0014-9446


× No keyword cloud information.
  8 in total

Review 1.  [Macrophage specific MRI imaging for antigen induced arthritides. A potential new strategy for the diagnosis of rheumatoid arthritis].

Authors:  G H Simon; H E Daldrup-Link; E J Rummeny
Journal:  Radiologe       Date:  2007-01       Impact factor: 0.635

2.  Anti-inflammatory models in animals.

Authors:  D A Willoughby; P Dieppe
Journal:  Agents Actions       Date:  1976-02

Review 3.  Experimental animal models resembling rheumatoid arthritis.

Authors:  P M Kaklamanis
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

4.  Some immunological effects of penicillamine.

Authors:  D M Chen; G Di Sabato; L Field; A A Gallo; S Harshman
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

5.  Optical imaging of experimental arthritis using allogeneic leukocytes labeled with a near-infrared fluorescent probe.

Authors:  Gerhard H Simon; Heike E Daldrup-Link; Juli Kau; Stephan Metz; Juergen Schlegel; Guido Piontek; Olaf Saborowski; Stavros Demos; Justus Duyster; Bernd J Pichler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-13       Impact factor: 9.236

6.  Use of the reversed passive Arthus reaction as a test for anti-inflammatory agents.

Authors:  M B Goldlust; W F Schreiber
Journal:  Agents Actions       Date:  1975-02

7.  Autoimmunity to collagen in adjuvant arthritis of rats.

Authors:  D E Trentham; W J McCune; P Susman; J R David
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

8.  The Protective Effect of Different Polar Solvent Extracts of Er Miao San on Rats with Adjuvant Arthritis.

Authors:  Wei Zhang; Qiying Zhang; Zihua Xuan; Juan Liang; Dongping Yang; Meihuizi Ding; Housheng Zhu; Bo Su; Xing Dai; Xiaoyi Jia
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-20       Impact factor: 2.629
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.